tiprankstipranks
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
Holding ANIP?
Track your performance easily

ANI Pharmaceuticals (ANIP) Income Statement

289 Followers

ANI Pharmaceuticals Income Statement

Last quarter (Q3 2024), ANI Pharmaceuticals's total revenue was $148.33M, an increase of 12.52% from the same quarter last year. In Q3, ANI Pharmaceuticals's net income was $-24.17M. See ANI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 385.02M$ 316.38M$ 316.38M$ 216.14M$ 208.47M$ 206.55M
Cost of Revenue
$ 211.07M$ 195.76M$ 138.78M$ 100.61M$ 87.16M$ 63.15M
Gross Profit
$ 173.96M$ 120.63M$ 177.60M$ 115.53M$ 121.32M$ 143.39M
Operating Expense
$ 301.99M$ 255.77M$ 204.00M$ 143.69M$ 114.36M$ 126.97M
Operating Income
$ 2.13M$ 49.53M$ -26.40M$ -28.17M$ 6.96M$ 16.43M
Net Non Operating Interest Income Expense
$ -18.45M$ -28.05M$ -28.05M$ 11.92M$ 9.45M$ 12.97M
Other Income Expense
$ -14.46M$ -2.72M$ 3.87M$ -15.97M$ -940.00K$ -303.00K
Pretax Income
$ -91.38M$ -64.00M$ -64.00M$ -56.06M$ -25.96M$ 3.16M
Tax Provision
$ -1.50M-$ 14.77M$ -13.46M$ -3.41M$ -2.94M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -87.84M$ -62.38M$ -80.40M$ -42.79M$ -22.55M$ 6.00M
Basic EPS
$ -7.09-$ -3.05$ -3.40$ -1.88$ 0.51
Diluted EPS
$ -7.42-$ -3.05$ -3.40$ -1.88$ 0.50
Basic Average Shares
$ 69.90M$ 16.26M$ 16.26M$ 12.60M$ 11.96M$ 11.84M
Diluted Average Shares
$ 69.68M$ 16.26M$ 16.26M$ 12.60M$ 11.96M$ 12.04M
Dividend Per Share
---$ 7.60--
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 513.06M$ 451.53M-$ -244.31M$ -201.52M$ -190.12M
Net Income From Continuing And Discontinued Operation
$ -7.90M$ 18.78M$ -80.40M$ -42.60M$ -22.55M$ 6.09M
Normalized Income
$ -100.93M$ -41.25M$ -41.25M$ -57.89M$ -28.93M$ 295.00K
Interest Expense
------
EBIT
$ -72.94M$ -35.95M$ -35.95M$ -44.14M$ -16.51M$ 16.12M
EBITDA
$ -9.52M$ 23.70M$ 23.70M$ 3.12M$ 28.13M$ 60.73M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis